GenNext Partnerships

Bringing together the best partners to provide state-of-the-art, full solutions for Protein Higher Order Structure analysis for GenNext Customers.

GenNext and SCIEX Co-market an Advanced HOS Workflow for Biopharmaceutical Research

The two companies are combining the latest in HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics. The state-of-the art structural biology workflow starts with the GenNext Flash Oxidation (Fox®) Protein Footprinting System performing covalent labeling of biotherapeutic products. Then, the ZenoTOF 7600 system from SCIEX is employed for mass spectrometry analysis. Finally, GenNext’s FoxWare® Data Processing Software is leveraged to execute high resolution HOS data analysis.

GenNext Partners with Emery Pharma on Full-Solution Biopharmaceutical Protein Footprinting Services

Together, GenNext and Emery Pharma deliver best-in-class pharmaceutical functional and structural analysis for allosteric and monoclonal antibody therapeutics. For clients seeking contract research, the GenNext/Emery Pharma team will generate data-rich insights to help them accelerate the approval of biotherapeutics and to develop safer, more effective, and less expensive therapeutic products.

Request a custom HRPF webinar for your lab.

Discover the Benefits of HRPF

Accelerate biopharmaceutical and biosimilar development and protein conformational research.